Literature DB >> 15984887

Artificial metalloprotease with active site comprising aldehyde group and Cu(II)cyclen complex.

Sang Ho Yoo1, Byoung June Lee, Hyunsook Kim, Junghun Suh.   

Abstract

To design artificial proteases that cleave peptide backbones of a wide range of proteins at selected sites, artificial active sites comprising the Cu(II) complex of cyclen (Cu(II)Cyc) and aldehyde group were synthesized on a cross-linked polystyrene. The aldehyde group was employed as the binding site in view of its ability of reversible formation of imine bonds with epsilon-amino groups of Lys residues exposed on the surface of proteins and Cu(II)Cyc as the catalytic group for peptide hydrolysis. The two polymeric artificial metalloproteases synthesized in the present study cleaved all of the protein substrates examined (myoglobin, gamma-globulin, bovine serum albumin, human serum albumin, lysozyme, and ovalbumin), manifesting saturation kinetic behavior. At 50 degrees C and pH 9.0 or 9.5, K(m) was (1.3-22) x 10(-)(4) M, comparable to those of natural proteases, and k(cat) was (6.0-25) x 10(-)(4) s(-)(1), corresponding to half-lives of 4.6-19 min. Intermediacy of the imine complexes formed between the aldehyde group of the catalyst and the epsilon-amino groups of Lys residues of the substrates was confirmed by the trapping experiment with NaB(OAc)(3)H. MALDI-TOF MS of the proteolytic reaction mixtures revealed formation of various cleavage products. Structures of some of the cleavage products were determined by using carboxypeptidase A and trypsin. Among various cleavage sites thus identified, Gln(91)-Ser(92) and Ala(94)-Thr(95) were the major initial cleavage sites in the degradation of myoglobin by the two catalysts. The selective cleavage of Gln(91)-Ser(92) and Ala(94)-Thr(95) was attributed to general acid assistance in peptide cleavage by Tyr(146) located in proximity to the two peptide bonds. Broad substrate selectivity, high cleavage-site selectivity, and high proteolytic rate are achieved, therefore, by positioning the aldehyde group in proximity to Cu(II)Cyc attached to a cross-linked polystyrene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15984887     DOI: 10.1021/ja052191h

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

1.  Soluble artificial metalloproteases with broad substrate selectivity, high reactivity, and high thermal and chemical stabilities.

Authors:  Min Gyum Kim; Sang Ho Yoo; Woo Suk Chei; Tae Yeon Lee; Hye Mi Kim; Junghun Suh
Journal:  J Biol Inorg Chem       Date:  2010-04-28       Impact factor: 3.358

2.  Self-assembled gold nanocrystal micelles act as an excellent artificial nanozyme with ribonuclease activity.

Authors:  Zhiming Zhang; Qiuan Fu; Xiangqiu Li; Xin Huang; Jiayun Xu; Jiacong Shen; Junqiu Liu
Journal:  J Biol Inorg Chem       Date:  2009-02-21       Impact factor: 3.358

3.  Proteolytic activity of Co(III) complex of 1-oxa-4,7,10-triazacyclododecane: a new catalytic center for peptide-cleavage agents.

Authors:  Hye Mi Kim; Boonjae Jang; Young Eun Cheon; Myunghyun Paik Suh; Junghun Suh
Journal:  J Biol Inorg Chem       Date:  2008-10-05       Impact factor: 3.358

4.  Metallotherapeutics: novel strategies in drug design.

Authors:  Lalintip Hocharoen; James A Cowan
Journal:  Chemistry       Date:  2009-09-07       Impact factor: 5.236

5.  MOFzyme: Intrinsic protease-like activity of Cu-MOF.

Authors:  Bin Li; Daomei Chen; Jiaqiang Wang; Zhiying Yan; Liang Jiang; Jiao He; Zhongrui Luo; Jinping Zhang; Fagui Yuan
Journal:  Sci Rep       Date:  2014-10-24       Impact factor: 4.379

6.  Crystal structure of (perchlorato-κO)(1,4,7,10-tetra-aza-cyclo-dodecane-κ4N)copper(II) perchlorate.

Authors:  Jessica L Gray; Deidra L Gerlach; Elizabeth T Papish
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-01-01

Review 7.  Amide Bond Activation of Biological Molecules.

Authors:  Sriram Mahesh; Kuei-Chien Tang; Monika Raj
Journal:  Molecules       Date:  2018-10-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.